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Abstract Recent advances in indocyanine green (ICG)
fluorescence imaging have enabled the visualization of the
blood supply to tissues. For advanced head and neck can-
cer, intra-arterial chemotherapy has been applied for
improving the prognosis and organ preservation. To iden-
tify the tumor-feeding artery, CT angiography has been
shown to be useful. However, the presence of dental metals
sometimes disturbs the precise evaluation of paranasal
sinus cancer patients by CT angiography. The objectives of
the study were to assess the feasibility of the ICG fluo-
rescence technique during intra-arterial chemotherapy for
advanced maxillary cancer. Thirty-six patients with para-
nasal sinus cancer who were treated by intra-arterial che-
motherapy were included. Conventional CT angiography
followed by 5 mg of ICG injection was performed to
confirm the areas in which the drug had dispersed. Intra-
arterial chemotherapy was administered at 150 mg/m2 of
CDDP four times weekly. Additional information about the
arteries feeding the tumors provided by ICG was evaluated.
Out of 36 cases, in 17 (47%) the blood supply to the cancer
was clearly detected by CT angiography. By adding the
infrared ICG evaluation, the blood supply to the tumor was
confirmed easily in all cases without radiation exposure.
The information obtained from fluorescence imaging was
helpful for making decisions concerning the administration
of chemo-agents for paranasal sinus cancers in cases
involving dental metal, or skin invasion. ICG fluorescence
imaging combined with intra-arterial chemotherapy com-
pensated for the deficiencies of CT angiography for para-
nasal sinus cancer. ICG fluorescence provided us clearer
and more useful information about the feeders to cancers.
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Introduction
For advanced paranasal sinus cancer, which is resistant to
conventional systemic chemotherapy, superselective intra-
arterial chemotherapy is believed to increase the concen-
tration of anti-cancer drugs in the tumor [1–6]. To obtain
precise information about the blood supply of the tumors,
we conducted CT angiography for head and neck cancer in
1998 for the first time in the world [7]. This procedure can
provide accurate and detailed information about the vas-
cular supply to head and neck cancers [1, 8–11]. However,
it is difficult to confirm the drug distribution areas when the
tumor is superficially invasive or the patient has undergone
dental treatment with metal. When conducting intra-arterial
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chemotherapy for maxillary cancer, indigo carmine dye is
thought to provide useful information concerning the
tumor-feeding arteries [1, 2]. For deeply invasive tumors;
however, conventional blue dye is not useful [1]. Further-
more, the duration for which the enhancement of the
selected artery feeding can be observed is so short that it’s
difficult to evaluate precisely. Recent advances in indocy-
anine green (ICG) fluorescence imaging have enabled
visualization of the blood flow in tissues [3, 12–15].
However, the only one report using ICG technique with
intra-arterial chemotherapy has been applied to oral cancer
[16].We have applied this ICG fluorescence technique in
combination with CT angiography for advanced paranasal
sinus cancer.
The purpose of this study was to assess the feasibility of
the ICG fluorescence technique during intra-arterial che-
motherapy for advanced paranasal sinus cancer, especially
maxillary cancer.
Materials and methods
Thirty-six patients with paranasal sinus cancer who were
treated by intra-arterial (I-A) chemotherapy concurrent to
radiotherapy from April 2010 to January 2012 were
included in this study. The patients’ characteristics are
shown in Table 1. CT angiography was performed after the
branch of a possible tumor-feeding artery was selected
using conventional DSA. At the same time, 5 mg of in-
docyanin green (ICG) was injected and we observed
whether the tumor territories were stained by using an
infrared camera system (Hypereye Medical System Handy,
Mizuho Ikakogyo Co. Ltd).
I-A chemotherapy was performed weekly over a 4-week
period. 150 mg/m2 of CDDP was administered superse-
lectively through feeding arteries at 5 mg/min. Sodium
thiosulfate at a dose of 200-fold that of the CDDP was
injected concurrently intravenously to neutralize the
adverse effects of CDDP.
We used both a retrograde approach via a temporal
artery and a femoral artery. I-A chemotherapy was per-
formed via the femoral artery when the tumor invaded the
contralateral side or when contralateral side lymph node
metastasis occurred. When the targeted artery had many
branches that were not blood supplies to the cancer, we
used a microcatheter through a 5 Fr guide catheter posi-
tioned inside the targeted artery.
We evaluated the diagnostic sensitivity of CT angiog-
raphy and ICG fluorescence technique. Furthermore, when
the tumor extended beyond the midline, the drug distri-
bution could be made to extend to the contralateral tumor
by manual compression of the contra-carotid artery, con-
firmed using the ICG fluorescence technique. Informed
consent was obtained from each patient before treatment
and the study was approved by the Human Ethics Review
Committee of Juntendo University.
Results
Thirty-six patients with advanced paranasal sinus cancer
received definitive chemoradiation with I-A chemotherapy.
These advanced cases were not suitable for surgical treat-
ment for organ preservation. Superselective I-A chemo-
therapy via a superficial temporal artery was performed in
18 patients. We initially carried out superselective I-A
chemotherapy via the femoral artery twice in 3 cases of
N2c and 15 cases of T4, in which the contralateral nasal or
paranasal sinus was invaded by cancer. After this proce-
dure, the patients were treated by superselective I-A che-
motherapy via a superficial temporal artery carried out
twice. There were no significant complications. Table 2
shows a list of the infused arteries. The total number of I-A
chemotherapies was 164. The mean I-A chemotherapy was
4.56 (range 3–6). The total number of superselectively
infused arteries was 413. Of the 413 infused arteries, the
numbers of infused maxillary arteries, facial arteries,
transverse facial arteries, and internal carotid arteries were
164, 79, 64, and 72, respectively.
CT angiography revealed the vascular territories of
selected arteries in only 17 cases (47 %). The reasons for the
failure in detecting the tumor-feeding arteries included
dental metals (10 cases) and mucosal or skin invasions
(superficially invasive tumor) (8 cases). Additionally, CT
angiography could not detect communicating branches
between the feeders (7 cases).With the infrared ICG evalu-
ation, the arteries supplying the tumors were confirmed
accurately in all cases (Figs. 1, 2). In the cases with a tumor
invading the cheek or facial skin, the use of communicating
branches of the maxillary artery for drug delivery to the
whole tumor was confirmed by manual compression of the
ipsilateral facial artery (Fig. 3). The alteration of blood flow
by manual facial artery compression could be directly
observed using the ICG fluorescence technique (Fig. 3). In
the case of a tumor crossing the midline, drug delivery to the
Table 1 Patients’ characteristics (TNM classification)
T/
N
0 1 2b 2c
3 3 3
4a 11 2 4 1 18
4b 12 1 1 1 16
26 3 5 2 36
Fresh:recurrent 32:4
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whole tumor was confirmed by manual compression of the
contralateral carotid artery, or maxillary artery. The alter-
ation of blood flow by manual contralateral artery com-
pression was directly viewed using the ICG fluorescence
technique (Fig. 3).
Confirmation of the tumor-feeding arteries was estab-
lished using CT angiography and ICG fluorescence imag-
ing, as shown in Fig. 4.
The effect of I-A chemotherapy was that CR and PR
were 86 and 14 %, respectively.
Table 2 The summary of infused arteries
Infused artery Maxillary A Facial A Transverse facial A Superficial temporary A Occipital A
Total 164 79 64 12 10
Average 4.56 2.19 1.8 0.33 0.28












Total 72 2 6 2 2 413
Average 2 0.06 0.17 0.06 0.06
Range 0–6 0–2 0–4 0–2 0–2
Fig. 1 Case 1: a 66-year-old man with maxillary cancer
(T4AN2bM0). a CT angiography obtained in the selected left side
maxillary artery. It was difficult to confirm the vascular territory due
to dental metals. b CT angiography obtained in the selected left side
maxillary artery. It was difficult to confirm the vascular territory due
to obstacle enhancement. c CT angiography obtained in the selected
left side facial artery. It was sufficiently clear to confirm the vascular
territory. d CT angiography obtained in the selected left side
transverse facial artery. It was sufficiently clear to confirm the
vascular territory. e CT angiography obtained in the selected left side
internal carotid artery. It was difficult to confirm the vascular territory
due to obstacle enhancement. f Maxillary cancer invading the face
before treatment
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Of the definitive chemoradiation group, the overall
survival rates of the cases, stage III and IVA group, and
stage IVB group were 78, 82, and 77 %, respectively
(Fig. 5). The difference between the overall survival rate of
the stage III and IVA group and the overall survival rate of
the stage IVB group was not significant (Fig. 5).
Discussion
Chemoradiotherapy for head and neck cancer plays an
important role in organ preservation, but there are many
cases such as paranasal sinus cancer for which conven-
tional systemic chemotherapies do not work at all. CDDP is
the most promising drug for head and neck cancer. When
high doses of CDDP are used, various adverse effects can
be observed, such as gastrointestinal toxicity, renal toxic-
ity, and hematotoxicity. For such chemo-resistant cancers
including paranasal sinus cancer, superselective intra-
arterial chemotherapy is considered to increase the con-
centration of the anti-cancer drug in the cancer tissue,
exerting powerful effects on the primary cancer [1–6]. This
procedure is reportedly capable of achieving a positive
prognosis as well as good organ preservation.
To achieve an effective therapeutic result for paranasal
sinus cancer with intra-arterial chemotherapy, precise
evaluation of the tumor-feeding artery and drug distribu-
tion territories is required. Digital subtraction angiography
(DSA) is applied for all cases of I-A chemotherapy; how-
ever, DSA cannot clearly detect the border between the
oral mucosa and surface invasion tumor. CT angiography
clearly detects the border between the normal paranasal
sinus and deeply invasive cancer by using three-dimen-
sional sections. Therefore, CT angiography in addition to
DSA has provided more precise identification of the blood
supply to the tumor [1, 7, 8]. However, we are sometimes
not able to confirm the tumor-feeding artery in paranasal
sinus cancer patients with dental metal fillings or when the
tumor has spread to oral cavities or superficially to the
facial skin. Furthermore, repeated CT angiography
increases the X-ray exposure, which is a significant prob-
lem not only for patients but also for the medical staff,
especially when a manual carotid compression technique is
applied. Previously, indigo carmine dye was often used to
confirm the blood supply to the tumor. However, the stain
disappears soon after the injection and cannot be observed
in cases of deeply invasive tumors [1, 2].
Recently, the ICG fluorescence technique was devel-
oped and has been used in various fields [3, 12–15]. The
excitation and emission profiles for ICG lie in the near-
infrared wavelengths, which allow penetration and imaging
of vessels below a few millimeters of tissue [12]. It
Fig. 2 ICG fluorescence
imaging. a ICG fluorescence
imaging of the left maxillary
artery. b ICG fluorescence
imaging of the left facial artery.
c ICG fluorescence imaging of
the left transverse facial artery.
d ICG fluorescence imaging of
the left internal carotid artery.
The cancer involving the facial
skin was clearly visualized
under fluorescent imaging of
each vascular area
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provides visualization of the blood supply to reconstructed
organs, and sentinel lymph nodes in cancer surgery
including head and neck cancer surgery [3, 13, 15, 17].
ICG fluorescence has been used for navigation surgery and
intraoperative detection of cancers [12, 18, 19].
We have reported that the ICG fluorescence technique
can be a very useful method for treating oral cancers with
I-A chemotherapy in patients with dental metal [16].
In this study, we also report our success in identifying
the tumor-feeding arteries in paranasal sinus cancer by ICG
fluorescence imaging. We found that the ICG fluorescence
technique was a very useful method even in patients with
dental metal. For tumors with multiple feeding arteries,
ICG fluorescence in selectively infused arteries could be
evaluated clearly and lucidly. Accordingly, we were able to
confirm that the whole tumor was covered and infused with
the anti-cancer drug.
We sometimes performed the I-A infusion chemother-
apy with manual compression of the contralateral facial
artery or lingual artery in cases of oral cancer with tumors
spreading to the contralateral oral cavity. This enabled
Fig. 3 Case 2: a 60-year-old woman with maxillary cancer
(T4aN0M0), which extended to the oral cavity and cheek with
communicating branches between the maxillary artery and facial
artery. a The right cheek by ICG fluorescence imaging at the right
maxillary artery. b The right cheek by ICG fluorescence imaging with
right manual facial artery compression. The ICG fluoresced areas
extended throughout the maxillary artery and the facial artery was
infused at the right maxillary artery with right manual facial artery
compression (arrow). c The oral cavity by ICG fluorescence imaging
at the right maxillary artery. d CT angiography obtained in the right
maxillary artery. It was difficult to confirm the vascular territory due
to dental metal. e The oral cavity by ICG fluorescence imaging with
right manual facial artery compression. The ICG fluoresced oral
cavity extended throughout the maxillary artery and the facial artery
with right manual facial artery compression
Fig. 4 The confirmation rate of the tumor-feeding arteries with CT
angiography and ICG fluorescence imaging
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alteration of the blood flow and the area supplied by the
contralateral facial, or lingual artery was sufficiently
confirmed to be covered by using the ICG fluorescence
technique. In the present study, we sometimes perform the
I-A infusion chemotherapy with manual compression of
the ipsilateral facial artery in cases of advanced paranasal
sinus cancers with tumors spreading to the oral cavity or
facial skin. This enables alteration of the blood flow and
the area supplied by the ipsilateral facial artery is suffi-
ciently identified to be covered by using the ICG fluo-
rescence technique. The changes of the blood flow were
directly observed using the ICG fluorescence technique
and effective I-A chemotherapy for the affected side alone
could be conducted safely. No complication resulted from
compression of the carotid artery, or facial artery. How-
ever, the same manual compression procedures during CT
angiography would involve too high a radiation exposure
if conducted each time. In this paper, we emphasize the
following points concerning oral cancers: the drug deliv-
ery to the whole tumor crossing the midline from the
contralateral side was confirmed directly by using the ICG
fluorescence technique (horizontal communication). This
is because there are communicating branches to the lateral
sides in oral cancer. However, in the present advanced
paranasal sinus cancers, communicating branches develop
vertically, such as the maxillary artery communicating to
branches of the facial artery (vertical communication). As
a result, the significance of this method differs signifi-
cantly between advanced oral cancer and advanced para-
nasal sinus cancer. Because one of most problematic
issues of using I-A chemotherapy for advanced paranasal
sinus cancers is that the tumors are often supplied by the
internal carotid artery and consequently, to prevent brain
complications, I-A chemotherapies were previously not
indicated for such cases.
Recently, the use of ICG fluorescent image has enabled
us to clearly detect tumor staining and reveal communi-
cating branches between the internal carotid artery and
maxillary artery, facial artery, and transverse facial artery
(vertical communication). As a result, this ICG fluores-
cence imaging procedure, when combined with the tech-
nique for altering the blood flow, has enabled us to safely
treat advanced paranasal sinus cancer, while improving the
prognosis and preserving organ and function.
Additionally, ICG fluorescence is a useful method for
confirming the arterial blood supply to paranasal sinus can-
cers because of the high excitation of ICG and deep pene-
tration of the tissue to approximately 10 mm. As a result, we
can use superselective I-A chemotherapy effectively for
most paranasal sinus cancers that have invaded less than
10 mm. However, tumors invading more deeply than 10 mm
require other imaging methods, such as simultaneous MRI
angiography. Once the stained field of each feeding artery
has been detected in cases of tumors invading the base of the
skull or face by CT angiography, the ICG fluorescence
technique can be used to compensate for defects in the CT
angiography by identifying the feeding artery precisely and
safely. It should be noted that a fine and sensitive endoscope
for ICG fluorescence imaging is required for the detection of
nasal cavity cancer. This technique is feasible and gives new
promising options for advanced paranasal sinus cancers.
Further investigations can lead to the development of a new
minimally invasive multimodal therapy targeting advanced
paranasal sinus cancers in the near future.
Conclusion
ICG fluorescence imaging for intra-arterial chemotherapy
revealed the blood supplies to paranasal sinus cancers more
Fig. 5 The overall survival
rates
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accurately than CT angiography, especially in cases of
superficial spread or those with dental metal. The appli-
cation of ICG fluorescence together with CT angiography
provides more accurate information about the feeding
arteries to tumors and enables effective intra-arterial che-
motherapy, while avoiding complications.
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